Research Overview
Across the studies, hydroxyapatite (HAp) research is most concentrated in (i) biomedical and dental applications, (ii) materials processing and sourcing (synthetic routes and extraction from natural wastes such as fish bone, shells, eggshells), and (iii) composite and nanoparticle engineering for bone regeneration and inflammation control. Reviews emphasize how production route and feedstock influence key material attributes (e.g., Ca/P ratio, crystallinity, phase composition, particle size, morphology), which in turn affect performance. A parallel, highly active area is scaffold design for bone tissue engineering, where HAp is combined with polymers (e.g., PCL, chitosan) and sometimes therapeutic ions (e.g., Sr substitution; Cu-containing components) to tune mechanical behavior, bioactivity, and antimicrobial/osteogenic effects. Nanostructured HAp also features prominently in oral-care formulations and in emerging immunomodulatory strategies (e.g., functionalized HAp nanoparticles for scavenging inflammatory mediators in periodontitis models).
The strongest evidence in these studies supports HAp’s role as a biocompatible, osteoconductive material platform and as a versatile component in composites that can enhance biological responses. In vitro and preclinical in vivo studies provide consistent support that engineered HAp systems (e.g., ion-substituted or polymer-coated nanoparticles) can modulate local biology—such as reducing pro-inflammatory signaling and limiting alveolar bone loss in a mouse periodontitis model—while scaffold studies show that adding HAp can improve cellular attachment/viability relative to polymer-only controls (with trade-offs versus other ceramics such as TCP for mechanical performance). In dentistry, a scoping review maps a substantial body of literature indicating remineralization and caries-preventive potential for nano-HAp dentifrices, and a long-duration randomized clinical trial in adults is positioned to provide higher-level evidence by directly comparing a fluoride-free HAp toothpaste to a standard fluoride control under a non-inferiority framework.
Key gaps highlighted by the studies include the need for more standardized, long-term, and clinically anchored evaluations—particularly for nano-HAp dentifrices (notably insufficient evidence in primary teeth and heterogeneity in protocols/outcomes). For natural-waste-derived HAp, further work is needed to link extraction parameters and trace-element content to reproducible performance and safety, including tighter control of Ca/P ratio, phase purity, and particle characteristics across sources. In tissue engineering and therapeutic nanoparticle applications, additional research is warranted to reconcile mechanical–biological trade-offs in composites, to establish robust structure–property–function relationships, and to expand translational evidence (dose, biodistribution, degradation/ion release kinetics, and comparative effectiveness versus existing standards of care) beyond early-stage in vitro and animal studies.
1. What conditions has Hydroxyapatite been studied for?
Dental caries prevention and enamel remineralization/repair (nano- or biomimetic hydroxyapatite in dentifrices; clinical and in vitro/in vivo studies).
Periodontitis (inflammatory alveolar bone loss) using hydroxyapatite-based nanoparticles (e.g., selenium-doped hydroxyapatite nanoparticles coated with PAMAM dendrimers) in a mouse ligature-induced periodontitis model.
Bone regeneration / bone defects / bone tissue engineering as a scaffold component (e.g., hydroxyapatite mixed with polymers like PCL; hydroxyapatite combined with chitosan and therapeutic ions such as strontium and copper; immunomodulatory Au-HA platforms).
Orthopedic and dental implant-related applications broadly, leveraging hydroxyapatite’s bioactivity/biocompatibility/osteoconduction (review-level evidence).
Cancer therapy (drug delivery) as a nanoparticle carrier (e.g., hyaluronic-acid modified hydroxyapatite delivering doxorubicin to nuclei and mitochondria; in vivo antitumor efficacy/toxicity evaluation reported in the study).
Bone biology/mechanobiology context: osteocytes reside in porous hydroxyapatite bone matrix (background/physiology rather than a treatment study).
2. Does it work in treating those conditions? Summarize the evidence.
-
Adult caries prevention (clinical trial): An 18-month double-blind randomized non-inferiority trial in adults compared a fluoride-free hydroxyapatite toothpaste vs 1450 ppm fluoride toothpaste. In the per-protocol analysis, no increase in DMFS occurred in 89.3% (hydroxyapatite) vs 87.4% (fluoride), and the hydroxyapatite toothpaste was not statistically inferior to fluoride for the primary endpoint. This supports effectiveness for caries prevention in adults at least comparable to standard fluoride toothpaste within the trial’s non-inferiority framework.
-
Remineralization/caries-related outcomes (scoping review): A PRISMA-ScR scoping review (2010–2021) included 28 studies and reported that most included studies found nHAp dentifrices (often nHAp alone) were associated with outcomes such as remineralization, caries prevention, less demineralization, brighter teeth, less pain, and remineralization after orthodontic debonding. However, the review explicitly concludes that evidence is insufficient in primary teeth and calls for long-term standardized protocols, indicating uncertainty and heterogeneity in the literature.
-
Primary dentition remineralization/repair (in vitro + in vivo study): One abstract reports that a fluorine-free toothpaste containing biomimetic hydroxyapatite formed a biomimetic apatite film on enamel and that the coating showed resistance to brushing due to chemical bonding between synthetic and natural crystals. It concludes biomimetic hydroxyapatite toothpastes are a valuable prevention measure in primary dentition and avoid fluorosis risk. However, because details (sample size, endpoints, randomization) are not provided in the study, strength of inference is limited from the study alone.
-
Periodontitis / inflammatory bone loss (preclinical): In a mouse ligature-induced periodontitis model, a hydroxyapatite-based nanoparticulate cfDNA scavenger (G3@SeHANs) alleviated inflammatory bone loss and reduced proinflammatory signals; it also promoted M2 over M1 macrophage phenotype. It showed greater therapeutic effects than soluble PAMAM-G3 in vivo. This is promising but remains animal-model evidence, not proof of clinical efficacy in humans.
-
Bone tissue engineering / regeneration (materials + cell studies; preclinical platform work): Multiple studies support hydroxyapatite’s utility as a scaffold component:
PCL scaffolds with HA showed better biological properties (cell viability/attachment/proliferation using human adipose-derived stem cells), while TCP improved mechanical properties.
Strontium-substituted hydroxyapatite combined with copper-chitosan showed ion release profiles (burst antibacterial agent + sustained strontium) and bioactivity (triggering calcium phosphate deposition in biological fluids) with preliminary osteoblast-line cell testing.
PDA@Au-HA nanocomposites were described as immunomodulatory (reduced M1, promoted M2 polarization; ROS scavenging) and supportive of vascularized bone regeneration via sustained release of Ca/P and gold nanoparticles—again, platform-level evidence rather than definitive human outcomes.
-
Cancer therapy (drug delivery; preclinical): HA-modified hydroxyapatite nanoparticles loaded with doxorubicin (DOX/HAP-HA) showed mitochondrial and nuclear targeting in vitro and reported greater in vivo antitumor efficacy with less harm than comparator groups in the study. This is preclinical and does not establish safety/efficacy in humans.
3. What health benefits does it have?
-
Anticaries benefit in adults (clinical evidence): In an 18-month RCT, a hydroxyapatite toothpaste was non-inferior to a standard 1450 ppm fluoride toothpaste for preventing worsening of DMFS in adults, supporting a real-world preventive oral-health benefit.
-
Enamel remineralization/repair potential: Across the scoping review, many studies reported remineralization and reduced demineralization with nHAp dentifrices; an additional abstract describes formation of a biomimetic apatite layer that resists brushing, consistent with a repair/coating mechanism.
-
Potential alternative when fluoride avoidance is desired: The studies emphasize fluorosis concerns with excessive fluoride exposure in young children and position hydroxyapatite toothpastes as fluorine-free options; however, the scoping review notes insufficient evidence in primary teeth, so this “benefit” is more about rationale and risk-avoidance than settled comparative effectiveness in children.
-
Bone-regeneration support (biomaterials context): Hydroxyapatite is repeatedly described as bioactive, biocompatible, and osteoconductive, and scaffold studies show improved cell-related outcomes (e.g., stem cell viability/attachment/proliferation) and “bioactivity” (calcium phosphate deposition in biological fluids).
-
Immunomodulatory/anti-inflammatory platform potential (preclinical): Hydroxyapatite-based nanoparticles and composites were engineered to reduce inflammatory signaling (e.g., cfDNA scavenging in periodontitis; PDA@Au-HA reducing ROS and shifting macrophages toward M2), which could indirectly support tissue repair—currently demonstrated in models rather than established clinical benefits.
4. Does it have any downsides or side effects?
-
Dental use safety (limited but supportive): The 18-month adult clinical trial concluded hydroxyapatite was a safe and efficient anticaries agent in oral care. The study does not list specific adverse events, so the nature and frequency of side effects cannot be quantified from the provided text.
-
Evidence gaps in children: The scoping review explicitly states insufficient evidence for efficacy in primary teeth and calls for long-term standardized studies. This is not a “side effect,” but it is a practical downside: uncertainty about performance in key populations.
-
Nanoparticle/composite formulations may introduce new risks (preclinical context): Several studies involve complex engineered systems (selenium-doped HA, PAMAM dendrimer coatings, gold nanoparticles, drug-loaded HA nanoparticles). Potential downsides could include material-specific toxicity, immune effects, biodistribution/accumulation, or off-target effects, but the studies reviewed here do not quantify these risks. Any safety conclusions for these advanced formulations remain limited without detailed toxicology and human data.
-
Product variability and material properties: Reviews note that extraction source and processing affect properties such as Ca/P ratio, crystallinity, phase assemblage, particle size, and morphology. This implies a potential downside for consistency/standardization across products (especially “natural waste-derived” hydroxyapatite), though direct clinical harm is not demonstrated in the studies.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
The studies reviewed here do not report pharmacogenomic analyses or genotype-stratified outcomes for hydroxyapatite (e.g., variants affecting response, safety, absorption, or immune reactions). Most described uses are topical dental applications or biomaterial/nanoparticle platforms rather than systemically metabolized drugs, which may reduce the likelihood of classic drug-metabolism gene effects, but genetic factors could still plausibly influence inflammatory responses or tissue remodeling. Based on the studies alone, there is no evidence that hydroxyapatite is specifically beneficial or harmful for any particular genetic variation.
References
-
Syntheses of hydroxyapatite from natural sources.
N A S Mohd Pu'ad, P Koshy, H Z Abdullah, M I Idris, T C Lee (2019) - Heliyon -
The Mechanosensory Role of Osteocytes and Implications for Bone Health and Disease States.
Jung Un Ally Choi, Amanda W Kijas, Jan Lauko, Alan E Rowan (2021) - Frontiers in cell and developmental biology -
Nano-Hydroxyapatite (nHAp) in the Remineralization of Early Dental Caries: A Scoping Review.
Aiswarya Anil, Wael I Ibraheem, Abdullah A Meshni, Reghunathan S Preethanath, Sukumaran Anil (2022) - International journal of environmental research and public health -
Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis.
Hanyao Huang, Weiyi Pan, Yifan Wang, Hye Sung Kim, Dan Shao, Baoding Huang, Tzu-Chieh Ho, Yeh-Hsing Lao, Chai Hoon Quek, Jiayu Shi, Qianming Chen, Bing Shi, Shengmin Zhang, Lei Zhao, Kam W Leong (2022) - Nature communications -
Polymer-Ceramic Composite Scaffolds: The Effect of Hydroxyapatite and β-tri-Calcium Phosphate.
Boyang Huang, Guilherme Caetano, Cian Vyas, Jonny James Blaker, Carl Diver, Paulo Bártolo (2018) - Materials (Basel, Switzerland) -
Chitosan/hydroxyapatite composite bone tissue engineering scaffolds with dual and decoupled therapeutic ion delivery: copper and strontium.
Lukas Gritsch, Muhammad Maqbool, Viviana Mouriño, Francesca E Ciraldo, Mark Cresswell, Philip R Jackson, Christopher Lovell, Aldo R Boccaccini (2019) - Journal of materials chemistry. B -
Extraction of natural hydroxyapatite for biomedical applications-A review.
Mohamed Saiful Firdaus Hussin, Hasan Zuhudi Abdullah, Maizlinda Izwana Idris, Mohd Arizam Abdul Wahap (2022) - Heliyon -
Caries-preventing effect of a hydroxyapatite-toothpaste in adults: a 18-month double-blinded randomized clinical trial.
Elzbieta Paszynska, Malgorzata Pawinska, Joachim Enax, Frederic Meyer, Erik Schulze Zur Wiesche, Theodor W May, Bennett T Amaechi, Hardy Limeback, Amadeusz Hernik, Justyna Otulakowska-Skrzynska, Anna Krahel, Inga Kaminska, Joanna Lapinska-Antonczuk, Ewa Stokowska, Maria Gawriolek (2023) - Frontiers in public health -
Enamel remineralization and repair results of Biomimetic Hydroxyapatite toothpaste on deciduous teeth: an effective option to fluoride toothpaste.
Maurizio Bossù, Matteo Saccucci, Alessandro Salucci, Gianni Di Giorgio, Erika Bruni, Daniela Uccelletti, Maria Sabrina Sarto, Giuseppe Familiari, Michela Relucenti, Antonella Polimeni (2019) - Journal of nanobiotechnology -
Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin.
Hui Xiong, Shi Du, Jiang Ni, Jianping Zhou, Jing Yao (2016) - Biomaterials -
Mussel-inspired immunomodulatory and osteoinductive dual-functional hydroxyapatite nanoplatform for promoting bone regeneration.
Danlei Qin, Yifan Zhao, Rui Cheng, Yingyu Liu, Susu Guo, Lingxiang Sun, Yanqin Guo, Fengxiang Hao, Bin Zhao (2024) - Journal of nanobiotechnology -
Cariogenic Biofilms: Development, Properties, and Biomimetic Preventive Agents.
Frederic Meyer, Joachim Enax, Matthias Epple, Bennett T Amaechi, Barbara Simader (2021) - Dentistry journal -
Effect of nano-hydroxyapatite and ozone on approximal initial caries: a randomized clinical trial.
Katarzyna Grocholewicz, Grażyna Matkowska-Cichocka, Piotr Makowiecki, Agnieszka Droździk, Halina Ey-Chmielewska, Anna Dziewulska, Małgorzata Tomasik, Grzegorz Trybek, Joanna Janiszewska-Olszowska (2020) - Scientific reports -
A review on adsorptive removal of dyes from wastewater by hydroxyapatite nanocomposites.
Shraddha Pai, M Srinivas Kini, Raja Selvaraj (2021) - Environmental science and pollution research international -
Chondroitin Sulfate-Modified Hydroxyapatite for Caspase-1 Activated Induced Pyroptosis through Ca Overload/ER Stress/STING/IRF3 Pathway in Colorectal Cancer.
Qing Chen, Bin Peng, Lifan Lin, Jiawen Chen, Zhaojun Jiang, Yuanwei Luo, Liyong Huang, Jin Li, Yuping Peng, Jiaming Wu, Wei Li, Kangmin Zhuang, Min Liang (2024) - Small (Weinheim an der Bergstrasse, Germany) -
Synthetic Hydroxyapatite as a Biomimetic Oral Care Agent.
Joachim Enax, Matthias Epple (2018) - Oral health & preventive dentistry -
Hydroxyapatite/alginate/gellan gum inks with osteoconduction and osteogenic potential for bioprinting bone tissue analogues.
Ana Raquel Bastos, Lucília P da Silva, F Raquel Maia, Albina Franco, Jennifer Noro, Carla Silva, J Miguel Oliveira, Rui Luís Reis, Vitor Manuel Correlo (2024) - International journal of biological macromolecules -
Bone Regeneration Capabilities of Scaffolds Containing Chitosan and Nanometric Hydroxyapatite-Systematic Review Based on In Vivo Examinations.
Paweł J Piszko, Aleksandra Piszko, Sylwia Kiryk, Jan Kiryk, Tomasz Horodniczy, Natalia Struzik, Kamila Wiśniewska, Jacek Matys, Maciej Dobrzyński (2024) - Biomimetics (Basel, Switzerland) -
Magnetic Hydroxyapatite Nanoparticles in Regenerative Medicine and Nanomedicine.
Hina Inam, Simone Sprio, Marta Tavoni, Zahid Abbas, Federico Pupilli, Anna Tampieri (2024) - International journal of molecular sciences
This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!